Adam S. Whalley, PharmD
Adam S. Whalley, PharmD is a PGY-1 pharmacy resident at UConn John Dempsey Hospital at UConn Health, Farmington, CT
Safinamide (Xadago): Approved as Add-On for Parkinson’s
Xadago has been approved as a supplementary medication for patients with Parkinson's disease who are having "off" episodes or whose disease is progressing.
Daclizumab approved for relapsing forms of multiple sclerosis
Daclizumab is the first subcutaneous injectable monoclonal antibody to be approved for the treatment of MS.